Flory, A., Kruglyak, K. M., Tynan, J. A., McLennan, L. M., Rafalko, J. M., Fiaux, P. C., . . . Tsui, D. W. Y. (2022). Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study. PloS one, 17(4), e0266623. https://doi.org/10.1371/journal.pone.0266623
Chicago-Zitierstil (17. Ausg.)Flory, Andi, et al. "Clinical Validation of a Next-generation Sequencing-based Multi-cancer Early Detection “liquid Biopsy” Blood Test in over 1,000 Dogs Using an Independent Testing Set: The CANcer Detection in Dogs (CANDiD) Study." PloS One 17, no. 4 (2022): e0266623. https://doi.org/10.1371/journal.pone.0266623.
MLA-Zitierstil (9. Ausg.)Flory, Andi, et al. "Clinical Validation of a Next-generation Sequencing-based Multi-cancer Early Detection “liquid Biopsy” Blood Test in over 1,000 Dogs Using an Independent Testing Set: The CANcer Detection in Dogs (CANDiD) Study." PloS One, vol. 17, no. 4, 2022, p. e0266623, https://doi.org/10.1371/journal.pone.0266623.